Skip to content

Survey of Symptoms After a COVID Vaccination in Employees

Survey of Symptoms After a COVID Vaccination in Employees: a Retrospective Study.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06035926
Enrollment
1093
Registered
2023-09-13
Start date
2021-01-01
Completion date
2023-07-31
Last updated
2023-09-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Symptoms Recoding SARS-CoV-2 After Vaccination

Keywords

SARS-CoV-2, Symptoms

Brief summary

Background: SARS-CoV-2 (Severe acute respiratory syndrome coronavirus type 2) has had us firmly in its grip for more than two years. In January 2021, the quality and risk management unit of the LKH (Landeskrankenhaus) -Univ. Klinikum Graz commissioned to carry out vaccinations for employees and subsequently for high-risk patients. In the vaccination line, which was open for 85 days in 2021/22, the vaccines from Astra Zeneca, Biontech-Pfizer and Moderna were vaccinated. There were hardly any complications. The primary immunization, booster vaccination and booster vaccination were carried out. Despite the small number of incidents in the sense of an immediate reaction, there were numerous sick leave. Methods: For this reason, in the course of the booster vaccination, starting from October 2021 to January 2022, every vaccinated person was asked to fill out a questionnaire. Participation was voluntary and was supported by the works councils of the Medical University and the LKH-University clinic Graz approved. The survey served to retrospectively record how many employees developed symptoms in response to the respective vaccination. With this approach it will be possible to subject the responses to an in-depth statistical analysis in order to obtain a data-based contribution to the side effects of vaccines categorized with different vaccination schemes.

Interventions

OTHERquestionnaire

questionnaire

Sponsors

Medical University of Graz
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
16 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Employees with appropriate indication (\>4 months after the second vaccination) according to the recommendations of the national vaccination committee. * Signed vaccination information sheet.

Exclusion criteria

* no booster vaccination.

Design outcomes

Primary

MeasureTime frameDescription
Occurrence of symptoms after the respective vaccination10 MinutesOccurence of symptoms, assessed by a questionnaire

Countries

Austria

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026